IceCure Medical (ICCM) vs Intelligent Bio Solutions (INBS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
IceCure Medical is the larger company by market cap ($5.2 million vs $5.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICCM | INBS |
|---|---|---|
| Share price | $1.13 | $1.57 |
| Market cap | $5.24M | $5.21M |
| 1-day change | -1.74% | -1.26% |
| Forward P/E | — | 4.49 |
| EPS (TTM) | $-6.84 | $-8.44 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.30 | $24.90 |
| 52-week low | $1.05 | $1.52 |
| Distance from 52-week high | -96.27% | -93.69% |
| Analyst consensus | none | none |
| Avg. price target upside | +1906.19% | +664.33% |
| Average volume | 136.91K | 160.86K |
| Shares outstanding | 4.64M | 3.32M |
| Employees | 67 | 59 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About IceCure Medical
ICCM stock →IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Healthcare · Medical Devices · 67 employees
About Intelligent Bio Solutions
INBS stock →Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform.
Healthcare · Medical Devices · 59 employees
ICCM vs INBS FAQ
Which is bigger, IceCure Medical or Intelligent Bio Solutions?
IceCure Medical (ICCM) is larger, with a market capitalization of $5.24M compared with $5.21M for Intelligent Bio Solutions (INBS).
Are IceCure Medical and Intelligent Bio Solutions in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.